3 Reasons to Buy This Blue-Chip Stock
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-06-03 15:45:00

The market has had to deal with a variety of concerns through the first five months of this year. This has led the S&P 500 index to dip 14% through May.
The exodus out of growth stocks has been marked by particularly strong demand for high-yield dividend stocks. The pharma stock AbbVie (ABBV 0.62%) has gained 9% as of the end of May, but still looks like it's a buy. Here are three reasons why. 1. Outperforming analysts' forecasts
When AbbVie reported its first-quarter results on April 29, they topped analysts' consensus forecasts.
